CR11864A - Preparación de formas farmacéuticas relajantes de músculos esqueléticos de liberación controlada - Google Patents
Preparación de formas farmacéuticas relajantes de músculos esqueléticos de liberación controladaInfo
- Publication number
- CR11864A CR11864A CR11864A CR11864A CR11864A CR 11864 A CR11864 A CR 11864A CR 11864 A CR11864 A CR 11864A CR 11864 A CR11864 A CR 11864A CR 11864 A CR11864 A CR 11864A
- Authority
- CR
- Costa Rica
- Prior art keywords
- skelettic
- relaxing
- muscles
- preparation
- controlled release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5089—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a un método para preparar una composición farmacéutica de liberación prolongada que comprende ciclobenzaprina, que comprende recubrir partículas inertes con una composición estratificante de fármaco que contiene ciclobenzaprina para formar microesferas LI.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7446408P | 2008-06-20 | 2008-06-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR11864A true CR11864A (es) | 2011-05-16 |
Family
ID=41434443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR11864A CR11864A (es) | 2008-06-20 | 2010-12-21 | Preparación de formas farmacéuticas relajantes de músculos esqueléticos de liberación controlada |
Country Status (28)
Country | Link |
---|---|
US (3) | US20090148532A1 (es) |
EP (1) | EP2303020B1 (es) |
JP (1) | JP5636364B2 (es) |
KR (1) | KR101451823B1 (es) |
CN (2) | CN102065691A (es) |
AR (2) | AR072267A1 (es) |
AU (1) | AU2009259993B2 (es) |
BR (1) | BRPI0914225B1 (es) |
CA (1) | CA2727935C (es) |
CL (1) | CL2009001447A1 (es) |
CO (1) | CO6300903A2 (es) |
CR (1) | CR11864A (es) |
CY (1) | CY1118878T1 (es) |
DK (1) | DK2303020T3 (es) |
ES (1) | ES2625485T3 (es) |
HU (1) | HUE032182T2 (es) |
IL (1) | IL209997A0 (es) |
MX (1) | MX2010013760A (es) |
MY (2) | MY173408A (es) |
NZ (1) | NZ589856A (es) |
PL (1) | PL2303020T3 (es) |
PT (1) | PT2303020T (es) |
RU (1) | RU2540494C2 (es) |
SG (1) | SG193816A1 (es) |
TW (2) | TWI458480B (es) |
UY (1) | UY31928A (es) |
WO (1) | WO2009155426A1 (es) |
ZA (2) | ZA201009083B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090148532A1 (en) * | 2007-12-06 | 2009-06-11 | Venkatesh Gopi M | Preparation of controlled release skeletal muscle relaxant dosage forms |
WO2010133961A1 (en) * | 2009-05-22 | 2010-11-25 | Inventia Healthcare Private Limited | Extended release compositions of cyclobenzaprine |
EP2501234B1 (en) * | 2009-11-20 | 2017-09-13 | Tonix Pharma Holdings Limited | Methods and compositions for treating symptoms associated with post-traumatic stress disorder using cyclobenzaprine |
US20110319389A1 (en) | 2010-06-24 | 2011-12-29 | Tonix Pharmaceuticals, Inc. | Methods and compositions for treating fatigue associated with disordered sleep using very low dose cyclobenzaprine |
WO2013158638A1 (en) * | 2012-04-17 | 2013-10-24 | Mylan, Inc. | Stable dosage forms of skeletal muscle relaxants with extended release coating |
CN104684550A (zh) * | 2012-06-15 | 2015-06-03 | 通尼克斯制药有限公司 | 用于跨粘膜吸收的组合物和方法 |
FI3650081T3 (fi) | 2013-03-15 | 2024-05-16 | Tonix Pharma Holdings Ltd | Syklobentsapriinihydrokloridin ja mannitolin eutektiset formulaatiot |
MY186047A (en) | 2014-09-18 | 2021-06-17 | Tonix Pharma Holdings Ltd | Eutectic formulations of cyclobenzaprine hydrochloride |
JP7323451B2 (ja) * | 2017-03-08 | 2023-08-08 | シンリックス ファーマ、エルエルシー | フロルグルシノールおよびトリメチルフロログルシノールの医薬製剤 |
WO2019116091A1 (en) | 2017-12-11 | 2019-06-20 | Tonix Pharma Holdings Limited | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions |
CN109381446A (zh) * | 2018-11-26 | 2019-02-26 | 正大制药(青岛)有限公司 | 一种盐酸环苯扎林缓释胶囊 |
CN111374942B (zh) * | 2018-12-30 | 2022-09-13 | 鲁南制药集团股份有限公司 | 一种甾体类肌松药注射液及其制备方法 |
CN114432266B (zh) * | 2021-12-23 | 2023-03-10 | 南通联亚药业股份有限公司 | 一种稳定的盐酸环苯扎林缓释胶囊 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3882246A (en) * | 1971-05-21 | 1975-05-06 | Merck & Co Inc | Treatment of skeletal muscle disorders with cyclobenzaprine |
US4337582A (en) * | 1980-09-30 | 1982-07-06 | Airco, Inc. | Methods for controlling vapor concentrations in an atmosphere |
US4685918A (en) | 1985-02-01 | 1987-08-11 | Merck & Co., Inc. | Lipid osmotic pump |
US5047258A (en) | 1989-07-14 | 1991-09-10 | Sterling Drug Inc. | Aqueous spray-coating process |
CN101288663A (zh) | 1999-09-14 | 2008-10-22 | 史密丝克莱恩比彻姆公司 | 制备水性包被小球粒的方法 |
US6576702B2 (en) | 2000-07-20 | 2003-06-10 | Noveon Ip Holdings Corp. | Plasticized waterborne polyurethane dispersions and manufacturing process |
DE60322371D1 (de) | 2002-03-29 | 2008-09-04 | Alza Corp | Volumensparende arzneiform zur kontrollierten freisetzung |
GB0219024D0 (en) * | 2002-08-15 | 2002-09-25 | Pfizer Ltd | Synergistic combinations |
GB0229258D0 (en) * | 2002-12-16 | 2003-01-22 | Boots Healthcare Int Ltd | Medicinal compositions |
JP2007509155A (ja) | 2003-10-21 | 2007-04-12 | アルファーマ インコーポレイテッド | クエチアピンを含有する薬剤 |
US7387793B2 (en) * | 2003-11-14 | 2008-06-17 | Eurand, Inc. | Modified release dosage forms of skeletal muscle relaxants |
US20060039975A1 (en) * | 2004-08-20 | 2006-02-23 | Zalman Vilkov | Paroxetine formulations |
US20060263429A1 (en) * | 2005-05-20 | 2006-11-23 | Hengsheng Feng | Compressible mixture, compressed pharmaceutical compositions, and method of preparation thereof |
CN101410109A (zh) * | 2006-03-24 | 2009-04-15 | 万能药生物有限公司 | 抗生素的调节释放组合物及其制备方法 |
US20090148532A1 (en) | 2007-12-06 | 2009-06-11 | Venkatesh Gopi M | Preparation of controlled release skeletal muscle relaxant dosage forms |
-
2008
- 2008-12-08 US US12/314,290 patent/US20090148532A1/en not_active Abandoned
-
2009
- 2009-06-18 MX MX2010013760A patent/MX2010013760A/es active IP Right Grant
- 2009-06-18 PL PL09767735T patent/PL2303020T3/pl unknown
- 2009-06-18 DK DK09767735.5T patent/DK2303020T3/en active
- 2009-06-18 CN CN200980123134XA patent/CN102065691A/zh active Pending
- 2009-06-18 WO PCT/US2009/047807 patent/WO2009155426A1/en active Application Filing
- 2009-06-18 HU HUE09767735A patent/HUE032182T2/en unknown
- 2009-06-18 SG SG2013063995A patent/SG193816A1/en unknown
- 2009-06-18 PT PT97677355T patent/PT2303020T/pt unknown
- 2009-06-18 ES ES09767735.5T patent/ES2625485T3/es active Active
- 2009-06-18 US US12/487,339 patent/US8137734B2/en not_active Expired - Fee Related
- 2009-06-18 CN CN201710064209.8A patent/CN106860430A/zh active Pending
- 2009-06-18 BR BRPI0914225-8A patent/BRPI0914225B1/pt active IP Right Grant
- 2009-06-18 MY MYPI2014001784A patent/MY173408A/en unknown
- 2009-06-18 NZ NZ589856A patent/NZ589856A/en unknown
- 2009-06-18 CA CA2727935A patent/CA2727935C/en active Active
- 2009-06-18 KR KR1020107028313A patent/KR101451823B1/ko active IP Right Grant
- 2009-06-18 RU RU2011101918/15A patent/RU2540494C2/ru active
- 2009-06-18 JP JP2011514809A patent/JP5636364B2/ja not_active Expired - Fee Related
- 2009-06-18 AU AU2009259993A patent/AU2009259993B2/en active Active
- 2009-06-18 MY MYPI2010005973A patent/MY153712A/en unknown
- 2009-06-18 EP EP09767735.5A patent/EP2303020B1/en active Active
- 2009-06-19 TW TW098120716A patent/TWI458480B/zh not_active IP Right Cessation
- 2009-06-19 CL CL2009001447A patent/CL2009001447A1/es unknown
- 2009-06-19 TW TW103134301A patent/TW201503915A/zh unknown
- 2009-06-19 AR ARP090102268A patent/AR072267A1/es unknown
- 2009-06-22 UY UY0001031928A patent/UY31928A/es not_active Application Discontinuation
-
2010
- 2010-12-13 CO CO10156300A patent/CO6300903A2/es not_active Application Discontinuation
- 2010-12-14 IL IL209997A patent/IL209997A0/en active IP Right Grant
- 2010-12-17 ZA ZA2010/09083A patent/ZA201009083B/en unknown
- 2010-12-21 CR CR11864A patent/CR11864A/es unknown
-
2011
- 2011-12-23 ZA ZA2011/09534A patent/ZA201109534B/en unknown
-
2012
- 2012-02-13 US US13/371,967 patent/US20120196028A1/en not_active Abandoned
-
2017
- 2017-04-26 CY CY20171100470T patent/CY1118878T1/el unknown
-
2018
- 2018-11-12 AR ARP180103296A patent/AR113877A2/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR11864A (es) | Preparación de formas farmacéuticas relajantes de músculos esqueléticos de liberación controlada | |
CR11740A (es) | Composiciones que comprenden fármacos levemente básicos y formas de dosificación de liberación controlada | |
BR112014001279A2 (pt) | composto, uso do composto, composição farmacêutica, e, método para tratar um indivíduo que sofre com um distùrbio mediado pela tirosina cinase de bruton (btk) | |
ECSP10010295A (es) | Formulacion de anticuerpo | |
CR20120215A (es) | Anticuerpos contra csf-1r humano y usos de los mismos | |
BR112012032816A2 (pt) | composição farmacêutica de liberação controlada, e, métodos para reduzir o efeito alimentar de uma composição de liberação controlada, reduzir o período de tempo necessário para que seja alcançado um estado estável para a metformina, para aperfeiçoar a biodisponibilidade de uma forma de dosagem de liberação controlada de matriz | |
CR20110466A (es) | Anticuerpos biespecíficos anti-erbb-3/anti-c-met | |
BR112014003802A2 (pt) | composto, composto composição farmacêutica, uso de um composto, método para fabricar um composto, e, preparação de um medicamento | |
CR20150114A (es) | Composición farmacéutica recubierta que contiene regorafenib | |
EP2917180A4 (en) | GPR40 RECEPTOR AGONIST, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE SUBSTANCE | |
BRPI0906475A2 (pt) | Compostos, processso para a preparação de um composto, composição farmacêutica e uso de um composto | |
NI201100016A (es) | Formulaciones farmacéuticas que contienen ligandos de receptores de dopamina. | |
BR112012024432A2 (pt) | composição farmacêutica de dissolução rápida | |
CL2013000200A1 (es) | Una composicion de combinacion farmaceutica que comprende una forma activa potenciada de un anticuerpo al receptor de la insulina humana y una forma activa potenciada de un anticuerpo de la sintasa de no endotelial; metodo para tratar la diabetes y los trastornos metabolicos. | |
EA201101116A1 (ru) | Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина | |
EA201200616A1 (ru) | Производные 2-оксо-1-пирролидинилимидазотиадиазола | |
UY32734A (es) | Compuestos agonistas del receptor esfingosina 1-fosfato | |
BR112014002557A2 (pt) | uso de uma composição curável, composição curável, processo para o encapsulamento de um transformador de medida e, tranformador de medida | |
TN2009000510A1 (en) | Extended release formulation of nevirapine | |
BR112015010271A8 (pt) | produto de comicronização, processo para o preparo de um produto de comicronização, composição farmacêutica e seus usos | |
ES2415029A8 (es) | Composición farmacéutica y uso de un anticuerpo para preparar un medicamento destinado a inhibir la producción o amplificar la eliminación de la proteína P24. | |
BR112014009500A2 (pt) | método in vitro para a liberação de um composto de vitamina d, método in vitro para medição de um composto de vitamina d e uso de uma composição reagente | |
BRPI0922714A2 (pt) | composto, processo para preparar um compsoto, medicamento, uso de um composto, e, composição farmacêutica | |
UY31903A (es) | 7-sulfanilmetil-,7-silfinilmetil-y7-sulfonilmetilindoles sustituidos y el uso de los mismos | |
BRPI0923003A2 (pt) | composição de liberação controlada para produção de uma preparação de liberação prolongada contendo udenafil |